Most Read Articles
25 Aug 2015
At the Northern Pharmacists Convention cum 48th Malaysian Pharmaceutical Society Seminar 2015 held recently at Bayview Beach Hotel, Penang, Sanofi invited three distinguished speakers – Dr Khaw Chong Hui, Dr Lo Kang Shang Chit, and Professor Dr Karl-Josef Gundermann – to speak on the importance of renal protection in managing diabetic hypertension, the use of antihistamines in managing chronic urticaria (CU), and the role of essential phospholipids (EPL) in fatty liver diseases, respectively.
Roshini Claire Anthony, 07 Nov 2017

Women who are underweight, particularly in their late teens and mid-thirties, may be at risk for early menopause, a recent study found. 

2 days ago
Oestradiol therapy appears to protect certain types of cognition in the presence of stress, suggests a recent study.
17 May 2017
The high-concentration capsaicin patch shows promise in the management of painful diabetic peripheral neuropathy (PDPN), with an effect that is similar to that observed with oral agents but offering systemic tolerability benefits, according to a network meta-analysis.

Insomnia tied to metabolic syndrome in males, middle-aged adults

20 Sep 2017
Fatal familial insomnia is a rare brain disease that causes sufferers to be unable to fall into deep sleep

Insomnia is independently correlated with metabolic syndrome in males and in middle-aged adults, a new cross-sectional study in a Chinese population has found.

Investigators grouped 8,017 adults (mean age 42.08±12.95 years; 51.79 percent male) into three age groups: <40 years (young adult group; n=3,927), 40 to 59 years (middle-aged group; n=3,150) and >60 years (older group; n=940). The corresponding prevalence of metabolic syndrome in the age groups were 19.79, 35.37 and 52.13 percent. The overall prevalence was 29.70 percent.

In both the crude (odds ratio [OR], 1.39; 95 percent CI, 1.21 to 1.59; p<0.01) and age- and gender-adjusted models (OR, 1.18; 1.02 to 1.37; p=0.03), insomnia was significantly associated with metabolic syndrome.

However, after additional adjustments for education, income, salt intake, body mass index, smoking, physical activity and drinking, the significant association was attenuated (OR, 1.18; 0.98 to 1.41; p=0.08).

Further analyses showed that, after pertinent adjustments, insomnia was significantly associated with metabolic syndrome only in males (OR, 1.35; 1.02 to 1.77; p=0.03) and in the middle-aged group (OR, 1.40; 1.09 to 1.79; p=0.01).

When individual components of metabolic syndrome were studied, researchers found that insomnia was significantly associated only with higher blood pressure (OR, 1.22; 1.05 to 1.43; p=0.01) and lower high-density lipoprotein cholesterol (OR, 1.16; 1.01 to 1.33; p=0.04).

In all participants, insomnia showed significant associations with the severity of metabolic abnormalities (OR, 1.17; 1.03 to 1.32; p=0.01) after appropriate adjustments for potential confounders.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Endocrinology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
25 Aug 2015
At the Northern Pharmacists Convention cum 48th Malaysian Pharmaceutical Society Seminar 2015 held recently at Bayview Beach Hotel, Penang, Sanofi invited three distinguished speakers – Dr Khaw Chong Hui, Dr Lo Kang Shang Chit, and Professor Dr Karl-Josef Gundermann – to speak on the importance of renal protection in managing diabetic hypertension, the use of antihistamines in managing chronic urticaria (CU), and the role of essential phospholipids (EPL) in fatty liver diseases, respectively.
Roshini Claire Anthony, 07 Nov 2017

Women who are underweight, particularly in their late teens and mid-thirties, may be at risk for early menopause, a recent study found. 

2 days ago
Oestradiol therapy appears to protect certain types of cognition in the presence of stress, suggests a recent study.
17 May 2017
The high-concentration capsaicin patch shows promise in the management of painful diabetic peripheral neuropathy (PDPN), with an effect that is similar to that observed with oral agents but offering systemic tolerability benefits, according to a network meta-analysis.